Chemoreceptors in Ventilatory Control
On this page
Direct answer
Ventilation barely stirs as arterial PO2 falls, until it crosses below about 60-65 mmHg — then it climbs steeply, because the peripheral chemoreceptors sit on the arterial side of the brain and fire hypoxic drive only below that knee. The carotid bodies at the bifurcation (afferents in the glossopharyngeal nerve) and aortic bodies (vagus) respond within seconds to hypoxia, hypercapnia, acidosis and hypoperfusion; the central chemoreceptors on the ventral medullary surface respond to hydrogen ion of brain extracellular fluid, generated when carbon dioxide diffuses across the blood-brain barrier. CO2 is the dominant everyday stimulus: raising PaCO2 by just 1 mmHg lifts ventilation around 2-3 L/min, while hypoxia is a reserve mechanism — which is why a patient with COPD and chronic CO2 retention comes to depend on hypoxic drive, and why over-generous oxygen can precipitate carbon dioxide narcosis. The carotid bodies alone account for the bulk of the hypoxic ventilatory response in humans.
What you must remember
- Two stations, two sensitivities: peripheral (carotid plus aortic bodies) respond to PO2, PCO2, pH and flow within seconds; central (medullary) respond to hydrogen ion of brain interstitial fluid, developing over a few minutes because CO2 must cross, and H+ cannot.
- The hypoxic knee: arterial PO2 must fall below roughly 60-65 mmHg before ventilation rises steeply — above it, the curve is nearly flat, a saturation-chemistry consequence (haemoglobin saturation is still about 90% at that point).
- Signal transduction: glomus (type I) cells close oxygen-sensitive potassium channels, depolarise, calcium enters, and dopamine is released onto petrosal afferents — the carotid body has the highest blood flow per gram of any organ, so its arteriovenous oxygen difference is minuscule; it senses partial pressure, not content.
- CO2 potency arithmetic: ventilation roughly doubles for each mmHg-sized step of CO2 in the linear range; the response to pure hypoxia at normal CO2 is feeble by comparison.
- Interaction is multiplicative: hypoxia and hypercapnia potentiate each other — a COPD patient at PO2 50 and PCO2 70 is driven far harder than either number alone predicts.
- Denervation consequences: bilateral carotid body removal (historically for asthma, still done experimentally in some centres for COPD) abolishes the hypoxic response; patients then rely entirely on CO2 drive.
- Clinical anchors: oxygen-induced hypercapnia in COPD exacerbations (target saturation 88-92% per routine care), high-altitude ventilatory acclimatisation via ventilatory response plus cerebrospinal fluid bicarbonate washout, and the apnoea of Cheyne-Stokes breathing with its loop-delay logic.
A worked case: oxygen in a blue bloater
A 64-year-old smoker with COPD arrives drowsy, saturation 74%, PO2 48 mmHg, PCO2 78 mmHg, pH 7.24. Give high-flow 100% oxygen carelessly and two mechanisms conspire against him: the hypoxic drive at his carotid bodies (now largely responsible for what ventilation he has) is switched off, and oxygen strips alveolar nitrogen from poorly ventilated units, causing absorption atelectasis plus worsened ventilation-perfusion matching, so PCO2 climbs further and narcosis deepens. Controlled oxygen — venturi mask to hold saturation near 88-92% — with blood gases after 30-60 minutes and a low threshold for non-invasive ventilation is the standard application of this physiology. Note what his central chemoreceptors are doing: chronically elevated bicarbonate has buffered most of the CO2 load, so brain hydrogen ion has partly normalised, blunting central drive — the patient is not "ignoring" CO2, his receptors have adapted to it. Every step of the management is a chemoreceptor decision.
Where students slip
The commonest confusion is asserting that peripheral chemoreceptors respond to oxygen content — they respond to partial pressure, which is why anaemia and carbon monoxide poisoning (low content, normal PO2) leave the carotid body silent and the patient hypoxic without dyspnoea proportionate to the deficit. Second, students place central chemoreceptors "in the respiratory centre" as a single point; they are widely distributed neurons, classically near the ventral medullary surface, responding to local H+. Third, the time courses get swapped: peripheral in seconds, central over minutes (and acclimatisation over days via bicarbonate shifts). The examinable nuance: why does hypoxia not stimulate central chemoreceptors? Because their substrate is H+, and hypoxia without CO2 retention does not generate it.
Frequently asked questions
Where are the peripheral chemoreceptors and what stimulates them?
Carotid bodies at the carotid bifurcation (glossopharyngeal afferents) and aortic bodies (vagal afferents), stimulated by low PO2, raised PCO2, acidaemia and reduced perfusion, responding within seconds.
Why do central chemoreceptors not respond to hypoxia?
They respond to hydrogen ion concentration in brain extracellular fluid; hypoxia alone does not raise local H+ the way CO2 hydration does, so the medullary receptors stay silent to pure arterial oxygen falls.
At what arterial PO2 does hypoxic ventilatory drive become significant?
Below about 60-65 mmHg, corresponding roughly to 90% saturation, below which the response steepens sharply.
Why can high-flow oxygen worsen hypercapnia in COPD?
It removes hypoxic ventilatory drive from the carotid bodies and worsens ventilation-perfusion matching through release of hypoxic pulmonary vasoconstriction and absorption atelectasis, so PCO2 rises.
How do the responses to CO2 and hypoxia interact?
Multiplicatively — simultaneous hypoxia and hypercapnia potentiate each other's ventilatory response, which is why combined derangement produces the deepest respiratory drive.